Global Cervical Total Disc Replacement (CTDR) Market Size

Cervical Total Disc Replacement (CTDR) Market Analysis

The cervical total disc replacement market is expected to register a CAGR of 12.76% over the forecast period, 2022-2027.

The COVID-19 pandemic has impacted healthcare operations, causing non-essential treatments and procedures to be suspended or delayed. In both orthopedic and spine surgery, there has been a significant decrease since the start of the COVID-19 global health crisis. In April 2020 the North American Spine Society (NASS) published a guidance sheet containing clinical recommendations and considerations for surgeries and procedures falling into the categories of urgent, urgently needed, and elective. To make the most of the available bed space, save personal protective equipment, and reduce unnecessary exposure. Elective surgeries like spinal fusion, complete joint replacements, and chronic joint issues have been postponed and delayed since the start of COVID-19. Thus, due to the above-mentioned factors, COVID-19 has significantly impacted the cervical total disc replacement device market.

An increase in cases of cervical degenerative disc disease, the surge in the geriatric population, and the low revision surgery rate of cervical disc replacement surgery are expected to drive the cervical total disc replacement market over the forecast period. For instance, according to the Agency for Healthcare Research and Quality article published in July 2021, cervical degeneration, which increases with age, should become more common as the proportion of the population over 60 years old rises. Every year, cervical degeneration is detected in about 27% of Medicare beneficiaries. This shows the significant amount of cervical degenerative cases in hospitals resulting in a rise in cervical disc replacement surgeries. This is expected to drive the cervical disc device market. The low revision surgery rate of cervical disc replacement surgery is the other growth driving factor. In March 2021, National Library of Medicine published a systematic review article with a minimum follow-up of five years, according to the article the long-term revision rate at the index level of unsuccessful cervical total disc replacement surgery was 3.9 %.

Additionally, the advancements in technology and increasing product approvals, along with company and product acquisitions by key players are anticipated to propel the market growth. For instance, in February 2019, Orthofix Medical, a global medical device company focused on musculoskeletal products and therapies, received approval from United States Food and Drug Administration (FDA) for the M6-C artificial cervical disc, which was developed by Spinal Kinetics, a company acquired by Orthofix in April 2018. Furthermore, in February 2021 NuVasive the leader in spine technology innovation acquired Simplify Medical, the developer of the Simplify Cervical Artificial Disc (Simplify Disc) for cervical total disc replacement (cTDR). This acquisition has strengthened the cervical total disc portfolio of the company. Thus, owing to rise in product approvals and acquisitions, the studied market is expected to have significant growth over the forecast period.

However, alternative treatment options like special exercises and physiotherapy, the risk of damage to nerves or blood vessels during the surgery, and the high cost associated with cervical total disc replacement are likely to impede the market growth.